Arrow image
Logo

Resources

Services:
Applications:

Strand’s scRNA Data Curation Portal: Bringing State-of-the-Art in Single Cell Transcriptomics to End Users

Brochure

Posted on Sep 18, 2024

Navigating Genetics of Dementia in the Indian Subcontinent

Poster

Posted on Sep 06, 2024

Unlocking New E3 Ligases for Targeted Protein Degradation in Cancer Therapy

Case Study

Posted on Sep 06, 2024

Studying the Spatio-temporal Root Cell Development of Arabidopsis Using Single-Cell RNA-Seq

Tech Note

Posted on Sep 05, 2024

Solutions for Bioinformatics Analysis: scRNA-Seq Methylation/Epigenomics, CyTOF

Webinar

Posted on Aug 30, 2024

Decoding Data Challenges in Diagnostics: Strand’s Solutions

Solution Snapshot

Posted on Aug 29, 2024

FDA Rule on Lab Developed Tests (LDTs) for Laboratories Setting Up Molecular LDTs

Solution Snapshot

Posted on Aug 29, 2024

Driving circRNA Analysis with Strand’s Solutions

Case Study

Posted on Aug 01, 2024

Unlocking Untapped Potential: New E3 Ligases for Targeted Protein Degradation in Cancer Therapy

Solution Snapshot

Posted on Jul 18, 2024

Streamlining Germline Testing: Pipeline Development and Clinical Variant Interpretation

Case Study

Posted on Jul 17, 2024

Comprehensive End-to-End Solutions for a Pet NGS Diagnostic

Case Study

Posted on Jul 16, 2024

Streamline Your Data with Our Expert Wrangling Services

Brochure

Posted on Jun 27, 2024

Engineering Excellence: Custom Solutions for Your Needs

Brochure

Posted on Jun 27, 2024

Exploring the Hidden Patterns: Leveraging FrAnaTk for cfDNA Fragment Analysis

Webinar

Posted on Jun 27, 2024

StrandIris: Revolutionizing Precision Oncology through Enhanced Tertiary Analysis Features

Webinar

Posted on Jun 27, 2024

Spatial Transcriptomics: Integrating Imaging, Omics and Clinical Metadata to Enable Discovery

White Paper

Posted on Jun 07, 2024

Showcasing Strand’s Expertise: A Closer Look at StrandOmics

Tech Note

Posted on Jun 06, 2024

Why StrandIris?

White Paper

Posted on Jun 06, 2024

Highlighting the Expertise Behind StrandOmics: Advancing Germline and Somatic Variant Classification

Tech Note

Posted on Jun 05, 2024

Spatial Transcriptomics Data Analysis Pipeline for Research and Diagnostics

Tech Note

Posted on May 27, 2024

Spatial Transcriptomics Workflow for Integrated Analysis and Precise Cell-type Annotations

Poster

Posted on May 20, 2024

Decoding Ulcerative Colitis at the Cellular Level with our Single-Cell RNA Sequencing Data Curation Portal

Poster

Posted on May 09, 2024

Unlocking Insights: Seamless Data Ingestion, Harmonization, and Curation for Multiomics Datasets with Integrated Ontologies

Poster

Posted on Mar 29, 2024

Cloud Storage & Data Management Strategy for NovaSeq X+ Data

Poster

Posted on Mar 29, 2024

Optimizing Methylation Pipeline: Migration from Snakemake to Nextflow and Deployment on Seqera Platform for Efficiency and Cost Benefits

Poster

Posted on Mar 29, 2024

Target/Biomarker Validation from Omics Data

Solution Snapshot

Posted on Mar 29, 2024

Strand is Spearheading Pet NGS Diagnostics

Brochure

Posted on Mar 29, 2024

Strand’s Data Harmonization Process

Solution Snapshot

Posted on Mar 29, 2024

Strand’s qPCR Reporting Software

Brochure

Posted on Mar 29, 2024

Workflow Management Systems: Our Software Solutions using Nextflow and Snakemake

Case Study

Posted on Mar 29, 2024

Strand-Agilent Mass Profiler Professional

Case Study

Posted on Mar 29, 2024

Spatial Transcriptomics: Our Path to 10X Genomics Visium Certification

Case Study

Posted on Mar 29, 2024

Somatic Variant Database Curation

Case Study

Posted on Mar 29, 2024

Ground Truth Dataset Curation for a Major Diagnostics Company

Case Study

Posted on Mar 29, 2024

Data Harmonization for a Big Pharmaceutical Company

Case Study

Posted on Mar 29, 2024

A Saliva-based Liquid Biopsy Assay for Oral Cancer

Case Study

Posted on Mar 29, 2024

Strand's qPCR Reporting Software

Case Study

Posted on Mar 29, 2024

Provider Portal & Electronic Data Capture Portal

Case Study

Posted on Mar 29, 2024

NGS Analysis Pipeline Development

Case Study

Posted on Mar 29, 2024

About image
Download & Access
Our

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Featured
Publications

Clinical Chemistry

Aug 2021

Determining Cost-Optimal Next-Generation Sequencing Panels for Rare Disease and Pharmacogenomics Testing

Multi-gene panel sequencing using next-generation sequencing (NGS) methods is a key tool for genomic medicine. However, with an estimated 140,000 genomic tests available, current system inefficiencies result in high genetic-testing costs.

BMC Medical Genomics

Apr 2021

Validation of whole genome sequencing from dried blood spots

Dried blood spots (DBS) are a relatively inexpensive source of nucleic acids and are easy to collect, transport, and store in large-scale field surveys, especially in resource-limited settings. However, their performance in whole-genome sequencing (WGS) relative to that of venous blood DNA has not been analyzed for various downstream applications.

Cancer Medicine

Sep 2018

Analysis of solid tumor mutation profiles in liquid biopsy

Liquid biopsy is increasingly gaining traction as an alternative to invasive solid tumor biopsies for prognosis, treatment decisions, and disease monitoring. Matched tumor-plasma samples were collected from 180 patients across different cancers with >90% of the samples below Stage IIIB.

Breast Cancer Research and Treatment

Feb 2018

Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations

Breast and/or ovarian cancers are among the most common cancers in women across the world. In the Indian population, the healthcare burden of breast and/or ovarian cancers has been steadily rising, thus stressing the need for early detection, surveillance, and disease management measures. However, the burden attributable to inherited mutations is not well characterized.

Cancer Medicine

Apr 2017

StrandAdvantage test for early-line and advanced-stage treatment decisions in solid tumors

Comprehensive genetic profiling of tumors using next-generation sequencing (NGS) is gaining acceptance for guiding treatment decisions in cancer care. We designed a cancer profiling test combining both deep sequencing and immunohistochemistry (IHC) of relevant cancer targets to aid therapy choices in both standard-of-care (SOC) and advanced-stage treatments for solid tumors.

About image
Please fill out this form to
download the case study.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.